CELEX: 62008TA0080
Language: en
Date: 2009-10-28 00:00:00
Title: Case T-80/08: Judgment of the Court of First Instance of 28 October 2009 — CureVac v OHIM — Qiagen (RNAiFect) (Community trade mark — Opposition proceedings — Application for the Community word mark RNAiFect — Earlier Community word mark RNActive — Relative ground for refusal — No likelihood of confusion — Article 8(1)(b) of Regulation (EC) No 40/94 (now Article 8(1)(b) of Regulation (EC) No 207/2009))

5.12.2009   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 297/20
            
         Judgment of the Court of First Instance of 28 October 2009 — CureVac v OHIM — Qiagen (RNAiFect)
   (Case T-80/08) (1)
   
   (Community trade mark - Opposition proceedings - Application for the Community word mark RNAiFect - Earlier Community word mark RNActive - Relative ground for refusal - No likelihood of confusion - Article 8(1)(b) of Regulation (EC) No 40/94 (now Article 8(1)(b) of Regulation (EC) No 207/2009))
   2009/C 297/28
   Language of the case: German
   
      Parties
   
   
      Applicant: CureVac GmbH (Tübingen, Germany) (represented by: F. Graf von Stosch, lawyer)
   
      Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (represented by: M. Kicia and S. Schäffner, Agents)
   
      Other party to the proceedings before the Board of Appeal of OHIM, intervener before the Court of First Instance: Qiagen GmbH (Hilden, Germany) (represented by: initially E. Krings, and subsequently V. von Bomhard, A. Renck and T. Dolde, lawyers)
   
      Re:
   
   Action brought against the decision of the First Board of Appeal of OHIM of 11 December 2007 (Case R 1219/2006-1) relating to opposition proceedings between CureVac GmbH and Qiagen GmbH.
   
      Operative part of the judgment
   
   The Court:
   
               1.
            
            
               Dismisses the action;
            
         
               2.
            
            
               Orders CureVac GmbH to pay the costs.
            
         
      (1)  OJ C 107, 26.4.2008.